Literature DB >> 11816707

Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.

M Saigo1, S Abe, M Ogawa, T Yamashita, S Biro, S Minagoe, I Maruyama, C Tei.   

Abstract

To evaluate the association between haemostatic parameters and increased risk of myocardial infarction (MI) at a young age, we measured fibrinogen, factor VII, antithrombin III, protein C, protein S, tissue factor (TF), free form tissue factor pathway inhibitor (TFPI), plasminogen, alpha2-antiplasmin, tissue plasminogen activator (tPA), plasminogen activator inhibitor-I (PAI-I), and lipoprotein (a) in 140 young men with MI before age 45 and 150 age-matched healthy men. TF, TF/TFPI ratio, PAI-I, PAI-I/tPA ratio, plasminogen, and lipoprotein (a) in young MI patients were all significantly higher than controls, while TFPI, antithrombin II, and tPA were significantly lower (P <0.001 of each). Significant determinants of MI risk were PAI-I/tPA ratio (R2 = 0.300, P <0.001), TF/TFPI ratio (R2 = 0.049, P <0.001), antithrombin III (R2 = 0.034, P <0.001), hyperlipidaemia (R2 = 0.019, P = 0.004), diabetes (R2 = 0.014, P = 0.015), lipoprotein (a) (R2 = 0.012, P = 0.023), alpha2-antiplasmin (R2= 0.014, P = 0.012), and protein C (R2= 0.012, P = 0.018). We conclude that the imbalances of PAI-I/tPA and TF/TFPI are significantly associated with MI at a young age, perhaps mediated via impaired fibrinolytic activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11816707

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Pro-coagulant activity during exercise testing in patients with coronary artery disease.

Authors:  Joanna Cwikiel; Ingebjorg Seljeflot; Eivind Berge; Harald Arnesen; Kristian Wachtell; Hilde Ulsaker; Arnljot Flaa
Journal:  Thromb J       Date:  2017-01-19

2.  Plasma tissue factor coagulation activity in post-acute myocardial infarction patients.

Authors:  Xiong Chang Lim; Siti Maryam J M Yatim; Suet Yen Chong; Xiaoyuan Wang; Sock Hwee Tan; Xiaoxun Yang; Siew Pang Chan; A Mark Richards; Chris J Charles; Mark Y Chan; Jiong-Wei Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

3.  Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease.

Authors:  Tetsuro Tsujimoto; Hiroshi Kajio
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.